Complementary Approaches to ADHD: What's Evidence-Based and What's Overhyped
Between 50% and 64% of parents of children with ADHD report using complementary and integrative medicine to manage symptoms[reference:0]. Among adults with ADHD, a nationally representative survey found that 15.7% reported using some form of complementary health approach, compared to a lower rate among adults without ADHD[reference:1]. A separate study of 145 adults with ADHD found that 81% had used dietary supplements at some point, 56% had tried omega-3 fatty acids, and 69% had practised meditation or mindfulness[reference:2].
These numbers reflect a reasonable impulse. ADHD is a chronic condition. Medication works for many people but not everyone, and side effects are common. Any intervention that reduces symptoms with minimal risk deserves consideration. The problem is that the popular literature on complementary ADHD treatments consistently overstates effect sizes, conflates correlation with causation, and presents nutritional or lifestyle interventions as alternatives to medication when the evidence supports them only as modest complements.
This article examines what the research actually shows for the most commonly discussed complementary approaches: exercise, omega-3, elimination diets, micronutrients, neurofeedback, mindfulness, CBD, and a handful of others. The goal is not to dismiss these interventions but to place them in their proper context alongside evidence-based treatment.
Exercise: The Strongest Lifestyle Intervention
Structured physical activity has the most consistent evidence base of any complementary approach to ADHD. A 2026 meta-analysis of 20 randomized controlled trials examined exercise prescription parameters for children with ADHD. Physical exercise produced modest improvements in ADHD symptoms overall (SMD = 0.27), but the details matter. Therapeutic and alternative exercise modalities, such as yoga and martial arts, showed larger effects (SMD = 0.45) than standard aerobic and endurance training (SMD = 0.16). Mid-term interventions lasting 12 to 24 weeks outperformed short-term programs. Mid-frequency (twice weekly) and longer sessions (60–90 minutes) demonstrated optimal effectiveness in exploratory subgroup analyses, though the authors noted these findings require confirmation[reference:3].
For adults, the evidence is more preliminary. A 2025 systematic review and meta-analysis identified 13 eligible studies with 312 participants aged 18–54. Acute interventions produced a small but significant reduction in ADHD symptoms (g = −0.191), while chronic interventions did not reach significance. Cardio exercises showed immediate benefits, and total intervention duration in weeks predicted symptom reduction in the chronic dataset. The authors noted that the number of studies was limited and methodological quality generally low, but the findings offer preliminary support for physical activity in adult ADHD[reference:4].
Seven meta-analyses published between 2024 and 2026 converge on a similar conclusion: structured exercise produces moderate-to-large improvements in ADHD-relevant cognitive and emotional outcomes, with cognitively engaging exercise, such as team sports, showing the strongest effects on inhibitory control[reference:5]. Exercise is not a replacement for medication, but for individuals seeking a low-risk adjunct with broad general health benefits, it is the most defensible complementary intervention available.
Yoga as a Specific Modality
Yoga falls within the broader category of mind-body exercise and has been studied as a standalone intervention. A 2026 randomized controlled trial of 50 children aged 7–12 compared 12 weeks of Yoga Asana, Yoga Nidra, and a waitlist control. Both yoga groups showed significantly lower ADHD total scores than the control group (p < .001 and p = .001 respectively), and the two yoga groups did not differ from each other. The authors concluded that yoga offers a promising, low-cost, school-compatible support for children with ADHD[reference:6].
A smaller randomized controlled trial of 20 children aged 6–12 tested a specific yoga practice called Sukshmavyayama, involving 30-minute sessions three days per week for six weeks. The intervention group demonstrated significantly lower hyperactivity scores than the control group at post-test (p < .001)[reference:7]. These are small trials, and replication is needed, but the direction of effect is consistent.
However, a systematic review of yoga for impulsivity across psychiatric conditions found that yoga did not produce significant improvement in impulsivity compared to placebo. This suggests that yoga's benefits may be domain-specific rather than global[reference:8].
Omega-3 Fatty Acids: Modest Effects, Overstated in Popular Media
Omega-3 supplementation is one of the most popular complementary approaches for ADHD. A survey of adults with ADHD found that 56% had tried omega-3 at some point[reference:9]. The research shows a small but statistically significant effect on ADHD symptoms.
Across meta-analyses, omega-3 fatty acid supplementation produces a pooled standardized mean difference of approximately 0.16 to 0.31. For context, methylphenidate has an SMD of approximately 0.78, and amphetamine approximately 1.0. In other words, omega-3's effect is roughly one-quarter the magnitude of stimulant medication[reference:10].
A 2024 network meta-analysis of antioxidant therapies in children and adolescents with ADHD ranked omega-3 at SUCRA 0.35 for improving attention, hyperactivity, and total Conners' Parent Rating Scale scores. Pycnogenol ranked slightly higher at 0.36. For teacher-rated outcomes, pycnogenol was most effective for attention, phosphatidylserine plus omega-3 for hyperactivity, and zinc for total scores. The response rate was highest for combined omega-3 plus omega-6 in Clinical Global Impression ratings (SUCRA 0.95)[reference:11].
However, the authors of that network meta-analysis cautioned that due to the low methodological quality of included studies, "the probability ranking cannot fully explain the clinical efficacy, and the results need to be interpreted with caution"[reference:12].
A 2025 systematic review of omega-3 polyunsaturated fatty acids in children with ADHD concluded that "omega-3 may not have a significant effect on ADHD symptoms to recommend its use" as a standalone treatment, and that future research should address the principal limitations in study designs[reference:13]. The National Center for Complementary and Integrative Health (NCCIH) describes the evidence on omega-3 as "inconclusive," adding that in studies where omega-3 supplements had benefits, they were not as effective as stimulant medications[reference:14].
The practical takeaway: omega-3 is low-risk, may produce a small benefit, and is reasonable to try as an adjunct. It is not a substitute for evidence-based treatment. Doses of EPA/DHA 500 mg/day or higher, with an EPA:DHA ratio of at least 2:1, have been suggested in some reviews, though optimal dosing remains uncertain[reference:15].
Dietary Interventions: Elimination Diets vs. Healthy Diets
Dietary approaches to ADHD have attracted intense interest, partly because they offer a sense of control and partly because food is something families can change without a prescription. The evidence, however, is more complicated than the headlines suggest.
The TRACE study, published in JCPP Advances in 2025, is the most rigorous long-term comparison of dietary interventions for ADHD. It was a two-arm randomized controlled trial in children aged 5–12, comparing an elimination diet (ED) with a healthy diet (HD) over one year. The short-term results, published earlier, found that fewer ED participants (34.5%) than HD participants (50.6%) responded to treatment, and more ED participants (45.2%) showed ambiguous effects[reference:16][reference:17].
At one-year follow-up, 27% of ED participants and 40% of HD participants fully complied with their assigned diet. The prospective one-year outcomes favoured the healthy diet, not the elimination diet. The authors concluded that for families considering a dietary treatment for ADHD, "starting with the HD is a low key, feasible and defensible option"[reference:18].
This is a significant finding. The elimination diet, which requires removing potential trigger foods such as cow's milk and wheat, is demanding to maintain. The healthy diet, which focuses on restoring nutritional adequacy and increasing intake of beneficial foods, is easier to sustain and produced better long-term outcomes.
Artificial Food Colouring
Elimination of artificial food colouring is a narrower intervention with a smaller but more consistent effect. Meta-analyses report an effect size of approximately g = 0.18 to 0.22 for artificial food colouring elimination, concentrated in a sensitive minority of children[reference:19]. This is not a general treatment for ADHD, but for a subset of children who appear to be sensitive to these additives, removal may produce a small benefit. The effect is too small and too idiosyncratic to recommend as a universal intervention.
Mediterranean Diet
Observational data consistently show that Mediterranean dietary patterns are associated with lower ADHD prevalence. These are cross-sectional and cohort studies, so causality cannot be established. It is possible that families with healthier diets differ in other ways that affect ADHD risk. Nonetheless, the Mediterranean diet has broad health benefits independent of ADHD, and there is no downside to recommending it for general reasons[reference:20].
Micronutrients and Individual Nutrients
Broad-Spectrum Multinutrients
The most promising nutritional intervention for ADHD may not be a single nutrient but a broad-spectrum multinutrient formulation. The MADDY study (Micronutrients for ADHD in Youth), an 8-week randomized placebo-controlled trial in unmedicated children aged 6–12, found a 54% response rate on Clinical Global Impression-Improvement with broad-spectrum multinutrients, compared to 18–20% with placebo[reference:21][reference:22].
A follow-up study examining inflammatory markers found that participants on multinutrients showed decreased IL-5 and IL-13 levels compared to placebo, suggesting that the behavioural effects may be mediated through immune pathways. Responders and non-responders also differed in IL-15 changes[reference:23].
The MADDY trial had a significant practical limitation: the multinutrient formulation required 6 to 12 capsules per day. Despite this, acceptability ratings were high[reference:24]. A duration-effects study found that acute changes were maintained and improved over a further 10-week open-label extension, with the placebo group catching up once they received micronutrients[reference:25].
The evidence for broad-spectrum multinutrients is more promising than for any single nutrient, but the studies are still relatively small, and replication in larger samples is needed. The mechanism appears to involve immune modulation, which is a relatively new area of research in ADHD.
Iron
Iron deficiency is more common in children with ADHD than in the general population, and neuroimaging studies show reduced brain iron in key dopaminergic regions[reference:26][reference:27]. A systematic review and meta-analysis of iron supplementation in neurodevelopmental disorders identified three randomized controlled trials evaluating iron for ADHD hyperactivity severity, involving 124 participants. Effect sizes were moderate for placebo (Cohen's d = 0.76) and large for supplementation (Cohen's d = 1.70), but the differences were not statistically significant. For inattentive symptoms, two trials with 75 participants showed large but nonsignificant effects for both placebo and supplementation groups[reference:28].
The quality of evidence was rated very low, and the authors concluded that further research is needed. Iron supplementation carries risks, including death in overdose, so it should not be used without documented deficiency. Screening for iron deficiency in children with ADHD is reasonable, and targeted supplementation may improve sleep and behavioural outcomes in those who are deficient[reference:29].
Zinc
A dose-response meta-analysis of six randomized clinical trials with 489 school-aged children found that zinc supplementation had a significant effect on ADHD total scores (SMD = −0.62), but not on hyperactivity or inattention subscales individually. The certainty of evidence was rated moderate to very low. The authors concluded that zinc may have beneficial effects but that well-designed, large-scale trials are needed[reference:30].
A separate meta-analysis of case-control studies found that zinc levels were significantly lower in children with ADHD (SMD = −1.01), suggesting that zinc imbalance may be involved in the pathogenesis of ADHD in at least some children[reference:31]. As with iron, the case for supplementation is strongest when deficiency is documented.
Vitamin D
Vitamin D status is reproducibly lower in children with ADHD, but the causal picture remains incomplete. A 2024 umbrella review of meta-analyses found that emerging evidence suggests potential adjunctive benefits of vitamin D in treating ADHD, but the evidence base is not strong enough for clinical recommendations[reference:32]. Vitamin D supplementation is low-risk at standard doses, and correcting deficiency is reasonable for general health reasons. Using it specifically to treat ADHD symptoms is not supported by current evidence.
Melatonin for Sleep
Melatonin is not a treatment for ADHD core symptoms, but it is a well-studied intervention for sleep problems in children with ADHD. A narrative review found that melatonin significantly reduced sleep onset latency, improved sleep quality, and extended sleep duration in children with ADHD. It was particularly beneficial for addressing sleep issues caused by stimulant medications[reference:33].
The NCCIH notes that limited evidence suggests melatonin may be helpful for sleep problems in children with ADHD, and that it appears safe for short-term use, though long-term safety is uncertain[reference:34]. A European Commission-approved formulation, Slenyto, is indicated for insomnia in children and adolescents aged 6–17 with ADHD when sleep hygiene measures have been insufficient[reference:35].
Melatonin is best positioned as a targeted treatment for sleep problems, not a general ADHD intervention. Improving sleep can have downstream benefits for attention and behaviour, but melatonin itself does not treat the core symptoms of ADHD.
Neurofeedback: Mixed Evidence, Blinding Problems
Neurofeedback is a technique in which individuals are trained to alter their brainwave patterns through real-time feedback, typically using EEG. It is one of the most studied non-pharmacological interventions for ADHD, and also one of the most contested.
A 2025 meta-analysis of computer game-based interventions for pediatric ADHD found that the neurofeedback subgroup showed the largest effect size (SMD = −0.51) among all intervention types, followed by physical exercise and virtual reality (SMD = −0.40). However, the certainty of evidence was rated "very low" for both findings[reference:36].
A separate meta-analysis of digital mental health interventions for ADHD reached a different conclusion: neurofeedback was "less effective than other digital ADHD interventions," with combination-based interventions showing better results[reference:37].
The discrepancy between these findings is not surprising given a persistent methodological problem in neurofeedback research: blinding. When participants and raters are not adequately blinded, effect sizes tend to be larger. When raters are blinded, the effects shrink substantially. This pattern has led many researchers to conclude that the apparent benefits of neurofeedback may be partly attributable to placebo effects and non-specific factors such as the structure and attention involved in the training sessions.
The NCCIH states that evidence on the effectiveness of neurofeedback for ADHD is "mixed"[reference:38]. Current guidelines do not recommend neurofeedback as a first-line treatment. It may be considered as an adjunct for individuals who are motivated to try it, but the evidence does not support it as a replacement for medication or behavioural therapy.
Mindfulness and Meditation
Mindfulness-based interventions have gained popularity as a complementary approach for ADHD. A meta-analysis of 10 controlled trials found statistically significant improvements in self-reported ADHD symptoms (SMD = 0.48), observer-rated ADHD symptoms (SMD = 0.32), and functional outcomes (SMD = 0.56). However, there were no significant effects on mindfulness skills, negative affect, or positive affect[reference:39].
The NCCIH describes the evidence on meditation as "unclear"[reference:40]. The pattern of benefits for symptoms and functioning but not for the mindfulness skills the intervention is supposed to teach raises questions about mechanisms. It is possible that non-specific components, such as structured group support and attention training, drive the effects rather than mindfulness itself.
Mindfulness-oriented meditation (MOM) is a specific form of self-regulatory training that has gained empirical support as a complementary intervention for children and adolescents with ADHD, with potential positive effects on family functioning as well[reference:41]. A randomized controlled trial of mindfulness martial arts in youth with ADHD and comorbid learning disabilities found that the intervention group maintained medial frontal cortex activity during response inhibition, while the waitlist control group showed attenuation over time. This suggests a potential neurophysiological mechanism for mindfulness-based interventions[reference:42].
Mindfulness and meditation are low-risk and may offer modest benefits. They are best viewed as adjuncts that support emotional regulation and attention, not as primary treatments for ADHD.
Cannabidiol (CBD): No Evidence, Real Risks
CBD oil has become one of the most heavily marketed complementary products for ADHD. The evidence does not support its use.
CHADD states plainly: "There have been no treatment studies. There are no randomized trials that show it works. And there are other treatment options available for kids and adults with ADHD. These are unregulated products"[reference:43].
A small randomized controlled trial of 30 adults with ADHD who received a trial cannabinoid/CBD medication found insignificant improvement on cognitive function and symptom reduction, with only nominal improvement on impulsivity and hyperactivity. The researchers expressed concern that participants did not follow instructions to avoid other medications or alcohol, and stated that their results were inconclusive[reference:44].
A systematic review of cannabidiol trials in neurodevelopmental disorders identified nine published randomized controlled trials, but the evidence for ADHD specifically remains thin[reference:45]. Some open-label studies and case reports suggest possible benefits, but large-scale, randomized, double-blind, placebo-controlled trials are lacking[reference:46].
CBD products are also unregulated. A recurring concern is that some products on the market contain trace amounts of THC, making them unsuitable for children and adolescents and for adults concerned about addiction[reference:47]. The case for CBD in ADHD is weak on both efficacy and safety grounds.
Other Approaches: A Brief Survey
Herbal Medicine and Traditional Chinese Medicine
Traditional Chinese Medicine (TCM), including herbal treatments, acupuncture, Tai Chi, and paediatric tuina, has been studied as a complementary approach for ADHD. A 2026 review concluded that TCM interventions significantly reduce core ADHD symptoms, often with acceptable safety profiles, but that more high-quality research is needed to standardise treatments and facilitate evidence-based integration[reference:48].
Among Western herbs, the evidence is less encouraging. The NCCIH states that there is not enough evidence to support the use of Ginkgo biloba for ADHD symptoms, and that in one study comparing ginkgo with standard drug treatment, ginkgo was less effective. St. John's wort is no better than placebo for ADHD symptoms, and it interacts harmfully with many medications[reference:49].
Some phytotherapy agents have shown preliminary promise. Saffron showed results comparable to methylphenidate in a pilot study, ginseng demonstrated favourable effects in a randomized study, and Bacopa monnieri has promising but unconfirmed evidence[reference:50]. These should be positioned as adjuncts, not alternatives to validated interventions.
L-Theanine and GABA
L-theanine and GABA are often included in integrative ADHD management frameworks, alongside omega-3, magnesium plus vitamin B6, adaptogenic herbs, and pre/probiotics. L-theanine and melatonin are associated with improvements in sleep parameters, which can indirectly benefit ADHD symptoms. Magnesium-B6 complexes support GABAergic activity, potentially reducing irritability and emotional lability[reference:51]. The evidence for these individual nutrients is preliminary and should not be overstated.
Acupuncture
The NCCIH states that there is insufficient evidence to draw conclusions about whether acupuncture is helpful for ADHD symptoms. Acupuncture is generally safe when performed correctly, but the evidence base is too thin to recommend it as a treatment[reference:52].
Table: Complementary Approaches to ADHD — Evidence Summary
| Approach | Evidence Level | Effect Size (approx.) | Practical Notes | Key Reference |
|---|---|---|---|---|
| Structured exercise | Moderate | SMD 0.27–0.45 (children); g −0.19 (acute, adults) | Twice weekly, 60–90 min sessions; therapeutic modalities outperform standard aerobic | 2026 meta-analysis, 20 RCTs[reference:53] |
| Yoga (asana, nidra) | Emerging | Significant vs. control in small RCTs | Low-cost, school-compatible; benefits may be domain-specific | 2026 RCT, 50 children[reference:54] |
| Omega-3 fatty acids | Modest | SMD 0.16–0.31 | ~1/4 effect of stimulants; low-risk adjunct; EPA:DHA ratio ≥2:1 suggested | Multiple meta-analyses; NCCIH "inconclusive"[reference:55][reference:56] |
| Healthy diet (Mediterranean-style) | Emerging | Outperformed elimination diet at 1 year | Feasible, sustainable; broad health benefits; TRACE study 50.6% response | TRACE study, JCPP Advances 2025[reference:57] |
| Elimination diet | Weak for long-term use | 34.5% short-term response; only 27% compliance at 1 year | Demanding to maintain; healthy diet produced better long-term outcomes | TRACE study, JCPP Advances 2025[reference:58] |
| Artificial food colouring elimination | Small effect, sensitive minority | g ≈ 0.18–0.22 | Not a universal intervention; only for identifiable sensitive subset | Sultan review, 2026[reference:59] |
| Broad-spectrum multinutrients | Promising | 54% response rate (MADDY RCT) | 6–12 capsules/day required; possible immune-mediated mechanism | MADDY study, 2025[reference:60] |
| Iron (if deficient) | Low quality evidence | Large but non-significant effects | Only with documented deficiency; overdose risk; screen first | Systematic review, 2024[reference:61] |
| Zinc | Moderate to very low certainty | SMD −0.62 (total scores) | May benefit children with low zinc; not a standalone treatment | Dose-response meta-analysis, 2022[reference:62] |
| Vitamin D | Inconclusive | Association, not causation | Correct deficiency for general health; not a specific ADHD treatment | Umbrella review, 2024[reference:63] |
| Melatonin (for sleep) | Good for sleep, not ADHD core | Improves sleep onset latency, duration | Targeted treatment for sleep problems; Slenyto approved in EU for ADHD insomnia | Narrative review, 2025[reference:64] |
| Neurofeedback | Mixed/contested | SMD −0.51 (very low certainty) vs. less effective than alternatives in another meta-analysis | Blinding problems; placebo effects likely; not first-line | Computer game meta-analysis, 2026[reference:65]; NCCIH "mixed"[reference:66] |
| Mindfulness/meditation | Emerging | SMD 0.48 (self-report) | Modest benefits; mechanisms unclear; low-risk adjunct | Meta-analysis, 2025[reference:67]; NCCIH "unclear"[reference:68] |
| CBD oil | No evidence | No RCTs showing efficacy | Unregulated products; THC contamination risk; not recommended | CHADD position, 2025[reference:69] |
| Ginkgo biloba | Insufficient | Less effective than standard treatment in one study | Not supported by evidence | NCCIH[reference:70] |
| St. John's wort | No better than placebo | — | Interacts harmfully with many medications | NCCIH[reference:71] |
| Acupuncture | Insufficient | — | Generally safe when performed correctly; evidence base too thin | NCCIH[reference:72] |
What Clinical Guidelines Say
Major clinical guidelines do not endorse complementary approaches as substitutes for evidence-based treatment. The American Academy of Pediatrics (AAP) recommends stimulant medication and/or evidence-based parent/teacher-administered behaviour therapy as first-line treatment for elementary school-aged children and adolescents[reference:73]. For preschool-aged children (4–5 years), the first line is parent training in behaviour management and/or behavioural classroom interventions[reference:74]. The American Academy of Child and Adolescent Psychiatry (AACAP) recommends initial psychopharmacological treatment with an FDA-approved agent and emphasises that a comprehensive treatment plan should include psychoeducation[reference:75].
These guidelines do not dismiss complementary approaches outright. The AAP notes that approximately 50–64% of parents of children with ADHD report using complementary and integrative medicine, and it encourages clinicians to work with families who inquire about these options, establish measurable outcomes, and clarify expectations for treatment[reference:76]. The message is not "don't use them" but "don't use them instead of evidence-based care."
NICE guidelines similarly recommend a stepped-care approach, starting with environmental modifications and psychoeducation, then behavioural interventions, and adding medication when needed. Complementary approaches may be considered alongside these interventions but should not delay or replace them.
How to Think About Complementary Approaches
The evidence reviewed here supports a tiered approach to complementary interventions.
First tier: Low-risk, moderate evidence. Structured exercise and a healthy dietary pattern have the strongest evidence among lifestyle interventions, with broad general health benefits and no significant risks. Omega-3 supplementation is low-risk and may produce a small benefit. Melatonin is effective for sleep problems, which can indirectly improve daytime functioning. These can be considered as adjuncts for most individuals.
Second tier: Promising but preliminary. Broad-spectrum multinutrients, yoga, and mindfulness-based interventions have emerging evidence but require larger, higher-quality trials before they can be recommended broadly. They are reasonable to try for individuals who are interested, provided they are not used as substitutes for evidence-based treatment.
Third tier: Targeted only. Iron, zinc, and vitamin D supplementation should be reserved for individuals with documented deficiencies. Screening is reasonable, but supplementation without evidence of deficiency is not supported and, in the case of iron, carries real risks.
Fourth tier: Not recommended. CBD oil has no evidence of efficacy and carries risks related to product quality and THC contamination. Ginkgo biloba, St. John's wort, and acupuncture lack sufficient evidence to recommend. Neurofeedback remains contested and is not first-line.
The most important principle is that complementary does not mean harmless, and natural does not mean effective. The evidence should guide decisions, not marketing claims or anecdotal reports. For individuals who choose to try complementary approaches, the goal should be to support, not replace, evidence-based treatment.
References
- NCCIH. (2025). 9 Things To Know About Complementary Health Approaches for ADHD for Children and Teens. https://www.nccih.nih.gov/...
- Sultan, R. S. (2026). ADHD, Diet, and Supplements: The Evidence. https://ryansultan.com/blog/blog-adhd-diet-supplements
- Huberts-Bosch, A., Bierens, M., Rucklidge, J. J., et al. (2025). Effects of an elimination diet and a healthy diet in children with ADHD: 1-Year prospective follow-up of a two-arm randomized, controlled study (TRACE study). JCPP Advances, 5(1), e12257.
- Hamada, T., Seki, M., Nango, E., et al. (2025). Enhancing effects of exercise and neurofeedback: A systematic review and meta-analysis of computer game-based interventions for pediatric ADHD. Psychiatry Research, 348, 116447.
- Dahlberg, M., Vessonen, T., Finell, J., et al. (2025). The Effects of Physical Activity Interventions on the Core Symptoms of ADHD in Adults: A Systematic Review and Meta-Analysis. Mental Health and Physical Activity, 29, 100725.
- Optimizing exercise prescription parameters for ADHD in children: A systematic review and meta-analysis. (2026). Public Health, 255, 106272.
- Zhou, P., Yu, X., Song, T., & Hou, X. (2024). Safety and efficacy of antioxidant therapy in children and adolescents with ADHD: A systematic review and network meta-analysis. PLoS One.
- Elliott, S. D., et al. (2024). Iron Supplementation in Management of Neurodevelopmental Disorders: Systematic Review, Meta-Analysis, and Qualitative Synthesis. Journal of Neuropsychiatry and Clinical Neurosciences.
- Wang, W., Tian, L., Xu, H., et al. (2026). Essential Trace Elements Zinc, Iron, Copper and ADHD: A Systematic Review and Meta-Analysis of Case–Control Studies. Nutrients.
- The effect of zinc supplementation in children with ADHD: A systematic review and dose-response meta-analysis. (2022). Critical Reviews in Food Science and Nutrition, 62(32), 9093–9102.
- CHADD. (2025). CBD Oil for ADHD? What the Research Says. https://chadd.org/...
- Self-rated costs and benefits of conventional and alternative adult ADHD treatments. (2024). Scientific Reports, 14, 79025.
- MADDY study: Micronutrients for ADHD in Youth. (2025). Journal of the American Academy of Child and Adolescent Psychiatry, Supplement.
- Inflammatory Factor Changes in a Multinutrient Randomized Controlled Trial for ADHD. (2025). JAACAP.
- Yang, X., Liu, X., & Tan, M. (2026). Management of ADHD: The Role of Traditional Chinese Medicine. Journal of Developmental Neuroscience.
- The Role of Dietary Patterns and Nutritional Supplements in the Management of Mental Disorders in Children and Adolescents: An Umbrella Review of Meta-Analyses. (2024). Canadian Journal of Psychiatry, 69(8), 567.
- The Role of Melatonin in Addressing Sleep Problems in Children with ADHD: A Narrative Review. (2025).
- Effect of a Twelve-Week Yoga Asana and Yoga Nidra Intervention on Overall ADHD Symptoms in Children: A Randomized Controlled Trial. (2026). International Journal of Special Education.
- Effect of Sukshmavyayama (Yoga for Relaxation) As a Therapeutic Intervention for Improving Hyperactivity in Children with ADHD. (2026). Cochrane Central Register of Controlled Trials.
- Complementary and Alternative Medicine Use by ADHD Patients: A Systematic Review. (2022). PubMed.
- Complementary Health Approach Utilization Among U.S. Adults With ADHD: A Nationally Representative Survey. (2024). Cureus.
- Management of ADHD When Medication is a Concern. (2025). Praxismed.
- ADHD Diagnosis and Treatment Guidelines. (2025). Praxismed.
This article is for informational purposes only and does not constitute medical advice. ADHD is a complex neurodevelopmental condition that requires professional assessment and diagnosis. Complementary approaches should be discussed with a qualified healthcare provider and should not replace evidence-based treatment. Some supplements interact with medications, and some carry risks, particularly at high doses or in individuals with underlying health conditions. Never start, stop, or change any treatment without medical supervision.